July 23rd 2025
The investigational BET inhibitor is being investigated combined with abemaciclib or cisplatin/etoposide in NUT carcinoma in 2 clinical trials.
Oral HPV Test Shows Potential for Predicting Oropharyngeal Cancer Risk
January 30th 2016Individuals with detectable human papillomavirus (HPV)-16 in their mouthwash samples were 22 times more likely to develop oropharyngeal cancer (OPC) than those without the type of virus, according to findings of a new study.
Swallowing Exercises Help to Preserve Function in Head and Neck Cancer Patients Receiving Radiation
January 9th 2014Head and neck cancer patients who participated in a swallow preservation protocol (SPP) were less likely to suffer from the detrimental effects associated with dysphagia, a common complication associated with radiation therapy (RT) and chemoradiation therapy (CRT).